Transparent AI Techniques for Speech-Based Detection of Cognitive Decline
Overview
Explainable AI (XAI) methods applied to speech analysis show strong potential for detecting cognitive decline with AUCs ranging from 0.76 to 0.94, identifying key acoustic and linguistic markers. Despite promising accuracy, challenges remain in clinical adoption due to limited stakeholder engagement, real-world validation, and standardized evaluation.
Background
Dementia prevalence is rapidly increasing worldwide, necessitating early, accessible detection methods. Speech and language changes often precede clinical symptoms, making them valuable biomarkers for cognitive decline. AI models leveraging natural language processing and machine learning can analyze complex speech features with high accuracy. However, the opaque nature of many AI models limits clinical trust and regulatory acceptance, highlighting the need for transparent, explainable AI approaches.
Data Highlights
Metric
Range
Model AUC
0.76 - 0.94
Key Acoustic Markers
Pause patterns, speech rate
Key Linguistic Features
Vocabulary diversity, pronoun usage
Key Findings
XAI techniques such as SHAP, LIME, attention mechanisms, and rule-based models have been applied to speech-based cognitive decline detection.
Models consistently identify clinically relevant speech markers including acoustic features (pause frequency, speech rate) and linguistic markers (vocabulary richness, pronoun use).
Performance metrics demonstrate strong discrimination with AUC values between 0.76 and 0.94.
Regulatory frameworks like GDPR and medical device regulations emphasize the necessity of AI transparency and explainability.
Current research lacks sufficient real-world validation, stakeholder involvement, and standardized frameworks for evaluating XAI methods in this domain.
Clinical Implications
Incorporating XAI into speech-based cognitive assessments can enhance clinician trust by clarifying AI decision processes and aligning model outputs with known clinical markers. Transparent models facilitate communication with patients and support regulatory compliance. However, further validation and engagement with healthcare stakeholders are essential before widespread clinical implementation.
Conclusion
Explainable AI techniques offer promising avenues to improve the interpretability and clinical integration of speech-based cognitive decline detection models. Addressing existing gaps in validation and stakeholder collaboration will be critical to realizing their full potential in healthcare.
References
Systematic Review 2025 -- Transparent AI for Speech-Based Cognitive Decline Detection
